CDK8-IN-9
CDK8-IN-9 (compound 22) is a potent type II CDK8 inhibitor with an IC50 value of 48.6 nM. CDK8-IN-9 can inhibit tumor growth and is used in colorectal cancer studies.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2850253-95-9
- 화학식: C24H20F3N3O
- 분자량:423.43
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CT26 | GI50 |
4 μM
Compound: 22
|
Antiproliferative activity against mouse CT26 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against mouse CT26 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 36068975] |
| GES1 | GI50 |
61.5 μM
Compound: 22
|
Cytotoxicity against human GES1 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Cytotoxicity against human GES1 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 36068975] |
| HCT-116 | GI50 |
4.9 μM
Compound: 22
|
Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 36068975] |
| HT-29 | GI50 |
4.3 μM
Compound: 22
|
Antiproliferative activity against human HT-29 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 36068975] |
| SW480 | GI50 |
2.1 μM
Compound: 22
|
Antiproliferative activity against human SW480 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human SW480 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 36068975] |
In Vitro
CDK8-IN-9 (compound 22) (0-100 μM, 48 h) can significantly inhibit cell proliferation and target CDK8 to inhibit the activation of the WNT/β-catenin pathway, thereby suppressing β-catenin-mediated transcriptional activity of TCF/ LEF[1].
CDK8-IN-9 (compound 22) (0.5,1 and 2 μM, 24 h) induces G2/M and S-phase cell cycle arrest, thereby inhibiting cell proliferation rather than inducing apoptosis[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT-116, HT-29, SW-480, CT-26 and GES-1 cells
-
Concentration:0-100 μM
-
Incubation Time:48 hours
-
Result:Inhibited HCT-116, HT-29, SW-480, CT-26 and GES-1 cells with the GI50 values of 4.9, 4.3, 2.1, 4.0 and 61.5 μM, respectively.
-
Cell Line:HCT-116 cells
-
Concentration:0.5, 1, and 2 μM
-
Incubation Time:24 hours
-
Result:Arrested cells in G2/M phase by 17%, 20.26% and 34.45% at concentrations of 0.5, 1, and 2 μM, respectively.
Showed a decrease in the G0/G1 phase and a slight increase in the S phase.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague−Dawley rats[1]
-
Dosage:10 mg/kg or 5 mg/kg
-
Administration:p.o. for 10 mg/kg and i.v. for 5 mg/kg
-
Result:The pharmacokinetic parameters of CDK8-IN-9 (compound 22)
Parameters t1/2 (h) Tmax (h) MRT (h) Cmax (μg/L) AUC0-∞ (μg/L·h) CL (L/h/kg) F (%) 10 mg/kg (po) 1.21 0.75 2.022 497.56 783.66 9.23 39.8 5 mg/kg (iv) 1.63 - 1.756 706.29 983.09 11.32 -
Chemical Information
-
CAS No. 2850253-95-9
-
분자량 423.43
-
화학식 C24H20F3N3O
-
SMILES
O=C(NC1=CC=C(C)C(C(F)(F)F)=C1)CCC2=CC=CC(C3=CN=C(NC=C4)C4=C3)=C2
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)